Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial

Abstract

Long term use of low dose azithromycin in young patients with cystic fibrosis has a beneficial effect on lung disease expression, even before infection with Pseudomonas aeruginosa.